Decision aid to help emergency department patients choose whether to start buprenorphine
CTN-0156: Pilot Development and Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine
This project tests a short decision aid to help adults with moderate-to-severe opioid use disorder in the emergency department understand buprenorphine and decide whether to start it.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Trial ID | NCT07278518 on ClinicalTrials.gov |
What this trial studies
Researchers will develop and pilot a patient decision aid (PtDA) designed for use when adults with moderate-to-severe opioid use disorder present to the emergency department and are candidates for buprenorphine. Participants will receive the PtDA or usual care and researchers will compare acceptability, patient knowledge, decisional conflict, and initiation of buprenorphine after discharge. Outcomes will be measured with patient surveys and clinical records of buprenorphine uptake and linkage to follow-up care. The project is conducted at the Medical University of South Carolina emergency department and focuses on patients who are English-speaking, not currently on medication for opioid use disorder, and able to receive follow-up by video or email.
Who should consider this trial
Good fit: Adults (≥18) with moderate-to-severe opioid use disorder who are not currently prescribed medication for opioid use disorder, speak/read English, and can receive video or email after ED discharge are ideal candidates.
Not a fit: People currently on medication for opioid use disorder, those who do not speak English, prisoners, or patients without access to video or email after discharge would not be eligible and are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, the decision aid could increase patient knowledge, reduce uncertainty, and lead to more people starting buprenorphine and linking to follow-up care.
How similar studies have performed: Emergency-department initiation of buprenorphine has previously increased treatment engagement and decision aids improve knowledge in other settings, but a dedicated ED buprenorphine decision aid has had limited testing to date.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 * DSM-5 criteria for moderate-to-severe OUD * Speaks and reads English * Not currently prescribed MOUD * Post-ED discharge patients with access to video/email Exclusion Criteria: \- Prisoners
Where this trial is running
Charleston, South Carolina
- Medical University of South Carolina — Charleston, South Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Lindsey Jennings, MD, MPH — Medical University of South Carolina
- Study coordinator: Lindsey Jennings, MD, MPH
- Email: jennil@musc.edu
- Phone: (843) 876-8023
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.